These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 38713894)

  • 1. Neoantigen landscape supports feasibility of personalized cancer vaccine for follicular lymphoma.
    Ramirez CA; Becker-Hapak M; Singhal K; Russler-Germain DA; Frenkel F; Barnell EK; McClain ED; Desai S; Schappe T; Onyeador OC; Kudryashova O; Belousov V; Bagaev A; Ocheredko E; Kiwala S; Hundal J; Skidmore ZL; Watkins MP; Mooney TB; Walker JR; Krysiak K; Gomez F; Fronick CC; Fulton RS; Schreiber RD; Mehta-Shah N; Cashen AF; Kahl BS; Ataullakhanov R; Bartlett NL; Griffith M; Griffith OL; Fehniger TA
    Blood Adv; 2024 Aug; 8(15):4035-4049. PubMed ID: 38713894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defining the optimum strategy for identifying adults and children with coeliac disease: systematic review and economic modelling.
    Elwenspoek MM; Thom H; Sheppard AL; Keeney E; O'Donnell R; Jackson J; Roadevin C; Dawson S; Lane D; Stubbs J; Everitt H; Watson JC; Hay AD; Gillett P; Robins G; Jones HE; Mallett S; Whiting PF
    Health Technol Assess; 2022 Oct; 26(44):1-310. PubMed ID: 36321689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.
    Lee CC; Chen CW; Yen HK; Lin YP; Lai CY; Wang JL; Groot OQ; Janssen SJ; Schwab JH; Hsu FM; Lin WH
    Clin Orthop Relat Res; 2024 Dec; 482(12):2193-2208. PubMed ID: 39051924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interpersonal counselling for adolescent depression delivered by youth mental health workers without core professional training: the ICALM feasibility RCT.
    Wilson J; Cestaro V; Charami-Roupa E; Clarke T; Dunne A; Gee B; Jarrett S; Katangwe-Chigamba T; Laphan A; McIvor S; Meiser-Stedman R; Murdoch J; Rhodes T; Seeley C; Shepstone L; Turner D; Wilkinson P
    Health Soc Care Deliv Res; 2024 Dec; 12(48):1-121. PubMed ID: 39673502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Falls prevention interventions for community-dwelling older adults: systematic review and meta-analysis of benefits, harms, and patient values and preferences.
    Pillay J; Gaudet LA; Saba S; Vandermeer B; Ashiq AR; Wingert A; Hartling L
    Syst Rev; 2024 Nov; 13(1):289. PubMed ID: 39593159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and immunogenicity of an AS03-adjuvanted SARS-CoV-2 recombinant protein vaccine (CoV2 preS dTM) in healthy adults: interim findings from a phase 2, randomised, dose-finding, multicentre study.
    Sridhar S; Joaquin A; Bonaparte MI; Bueso A; Chabanon AL; Chen A; Chicz RM; Diemert D; Essink BJ; Fu B; Grunenberg NA; Janosczyk H; Keefer MC; Rivera M DM; Meng Y; Michael NL; Munsiff SS; Ogbuagu O; Raabe VN; Severance R; Rivas E; Romanyak N; Rouphael NG; Schuerman L; Sher LD; Walsh SR; White J; von Barbier D; de Bruyn G; Canter R; Grillet MH; Keshtkar-Jahromi M; Koutsoukos M; Lopez D; Masotti R; Mendoza S; Moreau C; Ceregido MA; Ramirez S; Said A; Tavares-Da-Silva F; Shi J; Tong T; Treanor J; Diazgranados CA; Savarino S
    Lancet Infect Dis; 2022 May; 22(5):636-648. PubMed ID: 35090638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of sample site and collection procedure on identification of SARS-CoV-2 infection.
    Davenport C; Arevalo-Rodriguez I; Mateos-Haro M; Berhane S; Dinnes J; Spijker R; Buitrago-Garcia D; Ciapponi A; Takwoingi Y; Deeks JJ; Emperador D; Leeflang MMG; Van den Bruel A;
    Cochrane Database Syst Rev; 2024 Dec; 12(12):CD014780. PubMed ID: 39679851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Personalized neoantigen cancer vaccines: current progression, challenges and a bright future.
    Wu DW; Jia SP; Xing SJ; Ma HL; Wang X; Tang QY; Li ZW; Wu Q; Bai M; Zhang XY; Fu XF; Jia MM; Tang Y; Chen L; Li N
    Clin Exp Med; 2024 Sep; 24(1):229. PubMed ID: 39325256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lamotrigine versus levetiracetam or zonisamide for focal epilepsy and valproate versus levetiracetam for generalised and unclassified epilepsy: two SANAD II non-inferiority RCTs.
    Marson AG; Burnside G; Appleton R; Smith D; Leach JP; Sills G; Tudur-Smith C; Plumpton CO; Hughes DA; Williamson PR; Baker G; Balabanova S; Taylor C; Brown R; Hindley D; Howell S; Maguire M; Mohanraj R; Smith PE
    Health Technol Assess; 2021 Dec; 25(75):1-134. PubMed ID: 34931602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genedrive kit for detecting single nucleotide polymorphism m.1555A>G in neonates and their mothers: a systematic review and cost-effectiveness analysis.
    Shabaninejad H; Kenny RP; Robinson T; Stoniute A; O'Keefe H; Still M; Thornton C; Pearson F; Beyer F; Meader N
    Health Technol Assess; 2024 Oct; 28(75):1-75. PubMed ID: 39487741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-cancer immune effect of human colorectal cancer neoantigen peptide based on MHC class I molecular affinity screening.
    Zhang S; Huang C; Li Y; Li Z; Zhu Y; Yang L; Hu H; Sun Q; Liu M; Cao S
    Front Immunol; 2024; 15():1473145. PubMed ID: 39559350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Workplace interventions to reduce the risk of SARS-CoV-2 infection outside of healthcare settings.
    Constantin AM; Noertjojo K; Sommer I; Pizarro AB; Persad E; Durao S; Nussbaumer-Streit B; McElvenny DM; Rhodes S; Martin C; Sampson O; Jørgensen KJ; Bruschettini M
    Cochrane Database Syst Rev; 2024 Apr; 4(4):CD015112. PubMed ID: 38597249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ceftazidime with avibactam for treating severe aerobic Gram-negative bacterial infections: technology evaluation to inform a novel subscription-style payment model.
    Harnan S; Kearns B; Scope A; Schmitt L; Jankovic D; Hamilton J; Srivastava T; Hill H; Ku CC; Ren S; Rothery C; Bojke L; Sculpher M; Woods B
    Health Technol Assess; 2024 Oct; 28(73):1-230. PubMed ID: 39487661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effectiveness of abstinence-based and harm reduction-based interventions in reducing problematic substance use in adults who are experiencing homelessness in high income countries: A systematic review and meta-analysis: A systematic review.
    O'Leary C; Ralphs R; Stevenson J; Smith A; Harrison J; Kiss Z; Armitage H
    Campbell Syst Rev; 2024 Jun; 20(2):e1396. PubMed ID: 38645303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emotional literacy programme in special schools for children with a learning disability in England: the ZF-SEND feasibility RCT.
    Stenfert Kroese B; Unwin G; Hastings R; Jahoda A; McNamara R; Gillespie D; Segrott J; Ingarfield K; Gianatsi M; Randell E; Mather Z; Barrett B; Ganguli P; Rose J; Sahle M; Warren E; Da Cruz N
    Public Health Res (Southampt); 2024 Dec; 12(15):1-105. PubMed ID: 39641743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antioxidants for female subfertility.
    Showell MG; Mackenzie-Proctor R; Jordan V; Hart RJ
    Cochrane Database Syst Rev; 2017 Jul; 7(7):CD007807. PubMed ID: 28752910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Behavioural interventions to treat anxiety in adults with autism and moderate to severe intellectual disabilities: the BEAMS-ID feasibility study.
    Langdon PE; Apanasionok MM; Scripps E; Bunning K; Filipczuk M; Gillespie D; Hastings RP; Jahoda A; McNamara R; Rai D; Gray KM
    Health Technol Assess; 2024 Oct; 28(72):1-147. PubMed ID: 39487624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery.
    Bryant A; Hiu S; Kunonga PT; Gajjar K; Craig D; Vale L; Winter-Roach BA; Elattar A; Naik R
    Cochrane Database Syst Rev; 2022 Sep; 9(9):CD015048. PubMed ID: 36161421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and activity of lenalidomide in combination with obinutuzumab in patients with relapsed indolent non-Hodgkin lymphoma: a single group, open-label, phase 1/2 trial.
    Gurumurthi A; Chin CK; Feng L; Fowler NH; Strati P; Hagemeister FB; Fayad LE; Westin JR; Obi C; Arafat J; Nair R; Steiner RE; Neelapu SS; Flowers CR; Nastoupil LJ
    EClinicalMedicine; 2024 Aug; 74():102747. PubMed ID: 39161543
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.